I am a board-certified pathologist with expertise in general cytopathology and in lung, pleura, and mediastinal tumors. I joined the faculty at Memorial Sloan Kettering in 2016, after completing my cytopathology and surgical pathology fellowships at the Mayo Clinic. As part of the Thoracic Disease Management Team, I work together with my colleagues from surgery, medical oncology, and radiation therapy to care for people with lung, pleural, and mediastinal tumors. My role is to establish accurate pathologic diagnosis, grading, staging and interpretation of predictive markers to guide treatment decisions.
Read more Read less
Additionally, my educational responsibilities include working with fellows in oncologic pathology, thoracic pathology, and cytopathology. My current research interests include mesothelioma and immunotherapy for lung cancer.
- Clinical Expertise: Lung Cancer; Mesothelioma; Mediastinal Tumors; Cytopathology
- Awards and Honors: American Society of Cytopathology Warren Lang Resident Award (2016)
- Languages Spoken: English
- Education: MD, University of Minnesota Medical School
- Residencies: Anatomic and Clinical Pathology - University of Vermont
- Fellowships: Cytopathology - Mayo Clinic; Surgical Pathology - Mayo Clinic
- Board Certifications: Anatomic and Clinical Pathology; Cytopathology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more